HAS Healthcare Advanced Synthesis SA

Overview

HAS Healthcare Advanced Synthesis SA is a Swiss-based private company focused on providing advanced synthesis and manufacturing services to the healthcare and pharmaceutical industry. The company is dedicated to innovation and excellence in the development of complex chemical compounds.

Therapeutic areas

API / Drug Master Files

HAS Healthcare Advanced Synthesis SA holds 8 active (11 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• MECHLORETHAMINE HYDROCHLORIDEActive2023-04-14
• TRIFAROTENEActive2018-07-16
• FOSNETUPITANT CHLORIDEActive2017-03-31
• NETUPITANTActive2013-07-19
• ISOTRETINOINActive2006-10-30
• DANTROLENE SODIUM DRUG SUBSTANCEActive2006-06-01
• ADAPALENEActive2005-09-30
• PALONOSETRON HYDROCHLORIDE USPActive2002-07-19
• TROSPIUM CHLORIDEInactive2005-07-29
• MODAFINILInactive2004-11-10
• DMSAMInactive2004-10-29

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to HAS Healthcare Advanced Synthesis SA in our records. PharmaTek screens the full directory against live FDA enforcement data.